Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Preparing compound containing saccharide radical
Reexamination Certificate
2011-07-05
2011-07-05
Lu, Frank W (Department: 1634)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Preparing compound containing saccharide radical
C435S006120, C435S091100, C435S091510, C536S023100, C536S024300, C536S024330, C536S025300
Reexamination Certificate
active
07972817
ABSTRACT:
This invention relates to the use of extracellular ribonucleic acid (RNA) found circulating in the plasma or serum fraction of blood. Specifically, this invention enables the extraction of circulating RNA from plasma or serum and utilizes nucleic acid amplification assays for the identification, detection, inference, monitoring, or evaluation of any such RNA. Further, this invention allows the qualitative or quantitative detection of extracellular RNA circulating in the plasma or serum of humans.
REFERENCES:
patent: 4350156 (1982-09-01), Malchesky
patent: 4631130 (1986-12-01), Watanabe
patent: 4683195 (1987-07-01), Mullis et al.
patent: 4699877 (1987-10-01), Cline et al.
patent: 4738927 (1988-04-01), Taniguchi
patent: 4839055 (1989-06-01), Ishizaki et al.
patent: 4874853 (1989-10-01), Rossi
patent: 4874858 (1989-10-01), Magistro
patent: 4999290 (1991-03-01), Lee
patent: 5019243 (1991-05-01), McEwen et al.
patent: 5087617 (1992-02-01), Smith
patent: 5098890 (1992-03-01), Gewirtz et al.
patent: 5124246 (1992-06-01), Urdea et al.
patent: 5155018 (1992-10-01), Gillespie et al.
patent: 5217889 (1993-06-01), Roninson et al.
patent: 5274087 (1993-12-01), Barnett et al.
patent: 5300635 (1994-04-01), Macfarlane
patent: 5350671 (1994-09-01), Houghton et al.
patent: 5409818 (1995-04-01), Davey et al.
patent: 5429923 (1995-07-01), Seidman
patent: 5436318 (1995-07-01), Reyes et al.
patent: 5470724 (1995-11-01), Ahern
patent: 5506106 (1996-04-01), Croce
patent: 5532220 (1996-07-01), Lee
patent: 5576178 (1996-11-01), Emanuel
patent: 5994062 (1999-11-01), Mulshine et al.
patent: 6001987 (1999-12-01), Perron
patent: 6051374 (2000-04-01), Simons et al.
patent: 6057105 (2000-05-01), Hoon
patent: 6329179 (2001-12-01), Kopreski
patent: 6344317 (2002-02-01), Urnovitz
patent: 6607898 (2003-08-01), Kopreski
patent: 6656704 (2003-12-01), Korneluk et al.
patent: 6759217 (2004-07-01), Kopreski
patent: 6794135 (2004-09-01), Kopreski
patent: 6916634 (2005-07-01), Kopreski
patent: 6939671 (2005-09-01), Kopreski
patent: 2004/0014079 (2004-01-01), Kopreski et al.
patent: 2004/0058331 (2004-03-01), Akagi
patent: 2006/0286578 (2006-12-01), Kopreski et al.
patent: 2008/0096217 (2008-04-01), Kopreski
patent: 2008/0207723 (2008-08-01), Kopreski
patent: 2010/0144832 (2010-06-01), Srivastava et al.
patent: 3717212 (2003-09-01), None
patent: WO9009456 (1989-02-01), None
patent: WO 90/09456 (1990-08-01), None
patent: 97/35589 (1997-10-01), None
patent: 98/14617 (1997-10-01), None
patent: 98/14617 (1998-04-01), None
patent: 99/67397 (1999-12-01), None
Rohde et al., Expression of the Human Telomerase Reverse Transcriptase Is Not Related to Telomerase Activity in Normal and Malignant Renal Tissue. Clinical Cancer Research, 6, 4803-4809, 2000.
Kopreski et al., Detection of Tumor Messenger RNA in the Serum of Patients with Malignant Melanoma . Clinical Cancer Research, 5, 1961-1965, 1999.
The definition of “premalignant condition” from Wikipenia, the free encyclopedia. Printed on Apr. 20, 2009. Principle of Cycling Probe Technology. Printed on May 1, 2009.
Kolquist et al., Expression of TERT in early premalignant lesions and a subset of cells in normal tissues. Nature Genetics, 19, 182-186, 1998.
Miura et al., Sensitive Detection of Human Telomerase Reverse Transcriptase mRNA in the Serum of Patients with Hepatocellular Carcinoma. Oncology, 64, 430-434, 2003.
Wong et al., Quantification of Plasma β-Catenin mRNA in Colorectal Cancer and Adenoma Patients. Clinical Cancer Research, 10, 1613-1617, 2004.
Abravaya et al., “Detection of point mutations with a modified ligase chain reaction (GAP-LCR),”Nucleic Acids Research23:675-682 (1995).
Aoki et al., “Liposome-mediated in viva gene transfer on antisense K-ras construct inhibits pancreatic tumor dissemination in the murine peritoneal cavity,”Cancer Research55:3810-3816 (1995).
Barz et al., “Characterization of Cellular and Extracellular Plasma Membrane Vesicles from a Non-Metastasing Lymphoma (Eb) and Its Metastasing Variant (Esb),”Biochin Biophys Acta814:77-84 (1985).
Bauer et al., “Identification of H-2Kb Binding and Immunogenic Peptides from Human Papillama Virus Tumour Antigens E6 and E7,”Scand J Immunol42:317-323 (1995).
Blackburn et al., “Electrochemiluminescence detection for development of immunoassays and DNA probe assays for clinical diagnostics,”Olin Chem37/9:1534-1539 (1991).
Bobo et al., “Diagnosis of chlamydia trachomatis cervical infection by detection of amplified DNA with an enzyme immunoassay,”J din Micra28:1968-1973 (1990).
Bocchia et al., “Specific Binding of Leukemia Oncogene Fusion Peptides to HLA Class I Molecules,”Blood85:2680-2684 (1995).
Boom et al., “Rapid and Simple Method for Purification of Nucleic Acids,”J Clin Micro28:495-503 (1990).
Boom et al., “Rapid Purification of Hepatitis B Virus DNA from Seruc,”J Clin Micro29:180-181 (1991).
Brossart et al., “Detection of residual tumor cells in patients with malignant melanoma responding to immunotherapy,”J Immunotherapy15:38-41 (1994.
Buchman et al., “Selective RNA amplification: a novel method using d UMP-containing primers and uracil DNA glycosylase,”PCR Methods Applic3:28-31 (1993).
Carr et al., “Circulating Membrane Vesicles in Leukemic Blood,”Cancer Research45:5944-5951 (1985).
Cheung et al., “Rapid and Sensitive Method for Detection of Hepatitis C Virus RNA by Using Silica Particles,”J Clin Micro32:2593-2597 (1994).
Chirgwin et al., “Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease,”Biochemistry18:5294-5299 (1979).
Chomczynski and Mackey, “Modification of the TRI reagent (TM) procedure for isolation of RNA from polysaccaride- and proteaglycan-rich sources,”BioTechniques19:942-945 (1995).
Chomczynski and Mackey, “Substitution of chloroform by bromo-chloropropane in the single-step method of RNA isolation,”Analytical Biochemistry225:163-164 (1995).
Chomczynski et al., “Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction,”Analytical Biochemistry162:156-159 (1987).
Chomczynski, “A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples,”Biotech15:532-537 (1993).
Chu et al., “Thymidylate synthase binds to c-myc RNA in human colon cancer cells and in vitro,”Mol Cell Biol15:179-185 (1995).
Cohen, “Biochemical Therapy: Antisense Compounds,”In: Biologic Teraphy of Cancer(DeVita, Hellman, Rosenberg, eds) J.B. Lippincott, Ca., Philadelphia (1991) pp. 763-775.
Colomer et al., “erB-2 antisense oligonucleotides inhibit the proliferation of breast carcinoma cells with erb-2 oncogene amplification,”Br J Cancer70:819-825 (1994).
Coutlee et al., “Immunodetection of DNA with biotinylated RNA probes: A study of reactivity of a monoclonal antibody to DNA-RNA hybrids,”Analytical Biochemistry181:96-105 (1989).
Datta et al., “Sensitive Detection of Occult Breast Cancer by the Reverse-transcriptase Polymerase Chain Reaction,”Journal of Clinical Oncology12:475-482 (1994).
Davidova and Shapot, “Liporibonucleoprotein Complex as an Integral Part of Animal Cell Plasma Membranes,”FEBS Lett6:349-351 (1970).
DiCesare et al., “A high-sensitivity electrochemiluminescense-based detection system for automated PCR product quantitation,”Bio Techniques15:152-157 (1993).
Doi et al., “Detection of beta-human chorionic ganadotropin mRNA as a marker for cutaneoud malignant melanoma,”Int J Cancer65:454-45- (1996).
Dosaka et al., “A complex pattern of translational initiation and phosphorylation in L-Myc Proteins,”Oncogene6:371-378 (1991).
Edmands et al., “Rapid RT-PCR Amplification from Limited Cell Numbers,”PCR Methods Applic3:317-319 (1994).
Feng et al., “The RNA component of human telomerase,&#x
Lu Frank W
McDonnell & Boehnen Hulbert & Berghoff
OncoMEDx, Inc.
LandOfFree
Method enabling use of extracellular RNA extracted from... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method enabling use of extracellular RNA extracted from..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method enabling use of extracellular RNA extracted from... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2664187